SIK2 protects against renal tubular injury and the progression of diabetic kidney disease
Despite optimal medical therapy, many patients with diabetic kidney disease (DKD) progress to end-stage renal disease. The identification of new biomarkers and drug targets for DKD is required for the development of more effective therapies. The apoptosis of renal tubular epithelial cells is a key feature of the pathogenicity associated with DKD. SIK2, a salt-inducible kinase, regulates important biological processes, such as energy metabolism, cell cycle progression and cellular apoptosis. In our current study, a notable decrease in the expression of SIK2 was detected in the renal tubules of DKD patients and murine models.
Source: Translational Research - Category: Research Authors: Bingyao Liu, Linlin Zhang, Hang Yang, Xinyu Chen, Hongting Zheng, Xiaoyu Liao Source Type: research